Paper I
2023 July (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

Classification of antibiotics based on the mechanism of action

Q35 marksShort Essays

Answer

Antibiotics classified by mechanism of action:

  1. Inhibitors of cell wall synthesis:

    • Beta-lactams — penicillins, cephalosporins, carbapenems, monobactams — inhibit transpeptidase (penicillin-binding proteins), blocking peptidoglycan cross-linking.
    • Glycopeptides — vancomycin, teicoplanin — bind D-Ala-D-Ala terminus of peptidoglycan precursors, blocking their incorporation.
  2. Inhibitors of protein synthesis (act on the bacterial 70S ribosome, distinct from the mammalian 80S ribosome, giving selective toxicity):

    • 30S subunit inhibitors — aminoglycosides (cause misreading of mRNA), tetracyclines (block aminoacyl-tRNA binding).
    • 50S subunit inhibitors — macrolides (block translocation), chloramphenicol (inhibits peptidyl transferase), clindamycin, linezolid (inhibits initiation complex formation).
  3. Inhibitors of nucleic acid synthesis:

    • Fluoroquinolones — inhibit DNA gyrase and topoisomerase IV, blocking DNA replication.
    • Rifampicin — inhibits bacterial DNA-dependent RNA polymerase, blocking transcription.
    • Metronidazole — forms toxic free radicals within anaerobic organisms, causing DNA strand breakage.
  4. Inhibitors of cell membrane function:

    • Polymyxins (colistin) — disrupt the integrity of the bacterial cell membrane, acting like a detergent.
    • Daptomycin — inserts into the Gram-positive cell membrane, causing depolarization and disruption of membrane function.
  5. Inhibitors of metabolic pathways (antimetabolites):

    • Sulfonamides — competitively inhibit dihydropteroate synthase, blocking folate synthesis.
    • Trimethoprim — inhibits dihydrofolate reductase, blocking a later step of the same folate synthesis pathway (co-trimoxazole exploits this sequential blockade for synergistic effect).

This classification underlies rational antibiotic selection, since agents acting on different targets can sometimes be combined synergistically (e.g., sulfonamide + trimethoprim), and cross-resistance is generally more likely between agents sharing the same mechanism/target.

Other Years Asked


Revise MBBS
Preview